Report description
Bioinformatics has gained high importance due to its ability to facilitate rapid clinical research, and also due to its various applications such as gene therapy and molecular science. Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery. Pharmaceutical companies have increased their focus on process improvement and quality, as the current competitive scenario offers little scope for price escalation and product differentiation.
The market for bioinformatics platforms is growing at a significant pace with the increasing demand from U.S. and Europe. This trend is supported by the increasing demand for sequencing platforms with increasing life science research using techniques such as gene expression analysis, sequence analysis, and protein expression analysis.
The global bioinformatics market is expected to reach $8.3 billion by 2014 at a high CAGR of 24.8% from 2009-2014. While knowledge management formed the largest submarket is 2009 at $1.3 billion, the bioinformatics platforms market is expected to have greatest market share in 2014 at an estimated $3.9 billion, due to rising demand from the U.S. and Europe.
Markets covered
This research report categorizes the global bioinformatics market into the following segments:
• Bioinformatics platforms
o Sequence alignment platforms
o Sequence manipulation platforms,
o Sequence analysis platforms
o Structural analysis platforms
• Content/Knowledge management tools
o Specialized knowledge management tools
o Generalized knowledge management tools
• Services
o Data Analysis
o Sequencing Services
o Database & Management services
• Applications
What makes our reports unique?
• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
Powerful Research and Analysis
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
Global Biotechnology Industry
TABLE OF CONTENTS
EXECUTIVE SUMMARY
MARKET OVERVIEW
BIOINFORMATICS IN INDUSTRIES
BIOINFORMATICS MARKET DYNAMICS
KEY OMIC AREAS INFLUENCING BIOINFORMATICS
BIOINFORMATICS PLATFORMS MARKET
BIOINFORMATICS CONTENT/KNOWLEDGE MANAGEMENT TOOLS
BIOINFORMATICS SERVICES MARKET
BIOINFORMATICS APPLICATIONS MARKET
GEOGRAPHICAL ANALYSIS OF BIOINFORMATICS MARKET
COMPETITIVE LANDSCAPE
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 RESEARCH METHODOLOGY
1.5 STAKEHOLDERS
2 SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 MARKET DEFINITION
3.1.2 MARKET EVOLUTION
3.2 BIOINFORMATICS AND DRUG DEVELOPMENT
3.3 SEQUENCING PLATFORMS ARE HIGH PRIORITY
3.4 RELATIVE COMPARISON OF BIOINFORMATICS FEATURES
3.5 TRENDS IN BIOINFORMATICS SERVICES
3.6 TRENDS IN BIOINFORMATICS APPLICATIONS
3.7 BIOINFORMATICS PATENTS
4 BIOINFORMATICS IN INDUSTRIES
4.1 INTRODUCTION
4.1.1 BIOINFORMATICS APPLICATIONS IN VARIOUS SECTORS
4.1.1.1 Industrial/agricultural biotechnology companies
4.1.1.2 Biotechnology and pharmaceutical firms
4.1.1.3 Academic/research institutes
4.1.1.4 Other sectors
5 BIOINFORMATICS MARKET DYNAMICS
5.1 INTRODUCTION
5.2 DRIVERS
5.2.1 BIOINFORMATICS IMPROVES ON DRUG DISCOVERY PROCESS
5.2.2 BIOINFORMATICS SUPPORT BIOMARKER DISCOVERY TO DEVELOP SAFER DRUGS
5.2.3 HIGH THROUGHPUT SCREENING
5.2.4 ADVANCEMENT IN GENOMICS & PROTEOMICS
5.2.5 GOVERNMENT INITIATIVES & IT DEVELOPMENT
5.3 RESTRAINTS
5.3.1 LACK OF COMMON DATA FORMAT
5.3.2 SATURATED PHARMACEUTICAL MARKET
5.4 OPPORTUNITIES
5.4.1 NEED FOR INTEGRATED SOLUTIONS
5.4.2 NOVEL RESEARCH FIELD: CHEMOGENOMICS
6 KEY -OMIC AREAS INFLUENCING BIOINFORMATICS
6.1 BIOINFORMATICS AND -OMICS
6.2 GENOMICS APPLICATIONS
6.3 PROTEOMICS APPLICATIONS
7 BIOINFORMATICS PLATFORMS MARKET
7.1 INTRODUCTION
7.2 DRIVERS
7.2.1 NEED FOR BETTER OUTPUT QUALITY IN DRUG DISCOVERY
7.2.2 PLATFORM APPLICATION IN LIFE SCIENCES
7.3 SEQUENCE ALIGNMENT PLATFORMS
7.3.1 SEQUENCE ANALYSIS (ALIGNMENT)
7.3.1.1 Consensus sequence and translation
7.3.1.2 Multiple sequence alignment
7.3.1.3 Phylogenetic tree building
7.3.2 LAB END SEQUENCE ANALYSIS
7.3.2.1 Contig assembly
7.3.2.2 Primer design and cloning
7.4 SEQUENCE MANIPULATION PLATFORMS
7.4.1 RANDOM SEQUENCES & FORMAT CONVERSION
7.4.2 SEQUENCE ANALYSIS (SEQUENCE MANIPULATION)
7.4.3 SEQUENCE FIGURES
7.5 SEQUENCE ANALYSIS PLATFORMS
7.5.1 DNA SEQUENCE ANALYSIS PLATFORMS
7.5.1.1 Restriction, detect repeats, and unusual patterns
7.5.1.2 Align sequences
7.5.1.3 Search tools
7.5.2 ASSIGNMENT OF PROTEIN FUNCTION
7.5.2.1 Search pattern, motif, profiles domains, families
7.5.2.2 Pathways analysis and computation
7.5.2.3 Protein-protein interaction and protein annotation
7.5.2.4 New sequence alert
7.5.3 RNA ANALYSIS PLATFORM
7.5.4 ANALYZE AND MODEL 3D STRUCTURE
7.5.4.1 3D analysis and viewers
7.5.4.2 Homology modeling
7.5.5 PHYLOGENETIC ANALYSIS
7.5.5.1 Multiple sequence alignment
7.5.5.2 Organism classification
7.5.6 MICROARRAY DATA ANALYSIS
7.6 STRUCTURAL ANALYSIS PLATFORMS
7.6.1 PHYSIOCHEMICAL PROPERTIES & ALIGNMENT PLATFORMS
7.6.2 PRIMARY SEQUENCE ANALYSIS
7.6.3 SECONDARY STRUCTURE SEQUENCE PREDICTION
7.6.4 SEQUENCE VISUALIZATION
7.7 OTHER PLATFORMS
7.7.1 VISUALIZATION PLATFORMS
7.7.2 PHYSICAL MAPPING SOFTWARE
8 BIOINFORMATICS CONTENT/KNOWLEDGE MANAGEMENT TOOLS
8.1 INTRODUCTION
8.2 DRIVERS
8.2.1 EXPONENTIAL GROWTH IN PROTEOMIC DATA
8.2.2 DATA INTEGRATION NEEDED FOR IN-HOUSE SOLUTIONS
8.2.3 GROWTH IN CLINICAL TRIALS MARKET
8.3 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
8.3.1 DRIVERS
8.3.1.1 Need for complex information on molecule structure and sequence
8.3.1.2 Reduction of surplus data enables time saving
8.3.2 PRIMARY SEQUENCE KNOWLEDGE MANAGEMENT
8.3.3 PROTEIN SEQUENCE KNOWLEDGE MANAGEMENT
8.3.4 CARBOHYDRATE KNOWLEDGE MANAGEMENT
8.3.5 3D STRUCTURE KNOWLEDGE MANAGEMENT
8.4 SPECIALIZED KNOWLEDGE MANAGEMENT
8.4.1 DRIVERS
8.4.1.1 Growing number of studies in proteomics and DNA sequence analysis
8.4.1.2 Knowledge management tools improve data security
8.4.2 SPECIALIZED SEQUENCE KNOWLEDGE MANAGEMENT
8.4.3 GENOME KNOWLEDGE MANAGEMENT
8.4.3.1 Collections
8.4.3.2 Model organism knowledge management
8.4.4 SPECIALIZED PROTEIN KNOWLEDGE MANAGEMENT
8.4.4.1 Drivers
8.4.4.1.1 Need for structured and automated process in proteomics
8.4.4.1.2 Integration of bioinformatics and proteomics
8.4.4.2 Proteome knowledge management
8.4.4.3 Specific protein family knowledge management
8.4.4.4 Protein classification knowledge management
8.4.5 SPECIALIZED STRUCTURAL KNOWLEDGE MANAGEMENT
8.4.6 PATHWAYS KNOWLEDGE MANAGEMENT
8.4.7 MICROARRAY KNOWLEDGE MANAGEMENT
8.4.8 2D-PAGE KNOWLEDGE MANAGEMENT
9 BIOINFORMATICS SERVICES MARKET
9.1 INTRODUCTION
9.2 DRIVERS
9.2.1 TREND TOWARDS CONSULTANCY SERVICES
9.2.2 NEED FOR TOTAL DATA INTEGRATION & WAREHOUSING SOLUTIONS
9.3 DATA ANALYSIS
9.3.1 DRIVERS
9.3.1.1 Increasing informatics applications in biotechnology
9.3.1.2 Analytical tools stem data overflow
9.3.2 GENOMICS & PROTEOMICS DATA ANALYSIS
9.3.3 MICROARRAY DATA ANALYSIS
9.3.4 COMPUTATIONAL SERVICES MARKET
9.4 SEQUENCING SERVICES
9.4.1 DRIVERS AND RESTRAINTS
9.4.1.1 Outsourcing sequencing projects
9.4.1.2 Other competitive technologies
9.4.2 SHOTGUN SEQUENCING
9.4.3 PRIMER WALKING
9.4.4 EXPRESSION PROFILE CLUSTERING
9.4.5 RE-SEQUENCING
9.4.6 HIGH THROUGHPUT SEQUENCING
9.4.7 MULTIPLE SEQUENCE ALIGNMENT
9.5 DATABASE AND MANAGEMENT
9.5.1 CONCEPTION AND REALIZATION
9.5.2 DEVELOPMENT OF USER INTERFACE
9.5.3 MIGRATION
9.5.4 MAINTENANCE & BACKUP SYSTEM
9.6 OTHER SERVICES
10 BIOINFORMATICS APPLICATIONS MARKET
10.1 INTRODUCTION
10.2 DRIVERS
10.2.1 DEVELOPMENT OF MOLECULAR DIAGNOSTICS
10.2.2 DEVELOPMENT OF PERSONALIZED MEDICINE
10.3 RESTRAINTS
10.3.1 NEED FOR MORE HOLISTIC SOLUTIONS
10.3.2 LIMITED TO SPECIALIZED APPLICATIONS
10.4 OPPORTUNITIES
10.4.1 BIOINFORMATICS IN EPIDEMIOLOGY
10.4.2 INTEGRATION OF SYSTEMS BIOLOGY WITH BIOINFORMATICS
10.5 MOLECULAR MEDICINE
10.5.1 BIOINFORMATICS APPLICATIONS
10.5.1.1 Pharmacogenomics
10.5.1.2 Pharmacoproteomics
10.5.1.3 Metabolomics
10.5.1.4 Pharmacogenetics
10.6 MOLECULAR MEDICINE MARKET, BY REGION
10.6.1 U.S.: GOVERNMENT SUPPORT
10.6.2 EUROPE: HIGH HEALTHCARE EXPENDITURE
10.6.3 ASIA: EMERGING ECONOMIES BOOST MARKET GROWTH
10.7 PREVENTIVE MEDICINE
10.7.1 FACTORS INFLUENCING MARKET GROWTH
10.7.1.1 Pharmacogenomics applications
10.7.1.2 Aerospace & occupational medicine
10.8 GENE THERAPY
10.8.1 DRIVERS & OPPORTUNITIES
10.8.1.1 Bioinformatics application in gene therapy
10.8.1.2 Data Proliferation in gene therapy
10.8.1.3 Declining growth of gene therapy market
10.9 DRUG DEVELOPMENT
10.9.1 DRIVERS
10.9.1.1 Cost reduction in drug discovery process
10.9.1.2 Need for data processing in drug development
10.9.2 VIRTUAL HIGH THROUGHPUT SCREENING
10.9.3 SEQUENCE ANALYSIS
10.9.4 SIMILARITY SEARCHES
10.9.5 DRUG LEAD OPTIMIZATION
10.9.6 PHYSICOCHEMICAL MODELING
10.9.7 DRUG BIOAVAILABILITY AND BIOACTIVITY
10.10 OTHER APPLICATION MARKETS
10.10.1.1 Antibiotic resistance
10.10.1.2 Waste cleanup
10.10.1.3 Forensic analysis of microbes
10.10.1.4 Bio-weapon creation
10.10.1.5 Evolutionary studies
10.10.1.6 Natural quality improvement
10.10.1.7 Development of drought resistance varieties
10.10.1.8 Veterinary Science
11 GEOGRAPHIC ANALYSIS
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.3 EUROPE
11.4 ASIA
11.5 ROW
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 NEW PRODUCT, TECHNOLOGY, SERVICE LAUNCH (2008 TO 2010)
12.2.1 AGILENT TECHNOLOGIES (U.S.)
12.2.2 APPLIED BIOSYSTEMS (U.S.)
12.2.3 BIODISCOVERY INC. (U.S.)
12.2.4 CLC BIO (DENMARK)
12.2.5 DNASTAR (U.S.)
12.2.6 GENOME QUEST (U.S.)
12.2.7 HELICOS BIOSCIENCES CORPORATION (U.S.)
12.2.8 INVITROGEN CORPORATION (U.S.)
12.2.9 MOLEGRO (U.S.)
12.2.10 OCIMUM BIOSOLUTIONS (U.S.)
12.2.11 SOFTGENETICS (U.S.)
13 COMPANY PROFILES
13.1 3RD MILLENNIUM
13.2 ACCELRYS
13.3 AFFYMETRIX INC
13.4 AGILENT TECHNOLOGIES
13.5 BIODISCOVERY
13.6 BIOINFORMATICS SOLUTIONS INC
13.7 BIOMATTERS
13.8 BIOMAX INFORMATICS
13.9 BIOWISDOM LTD
13.10 BRUKER DALTONICS INC
13.11 CELERA CORP
13.12 CLC BIO
13.13 DNASTAR
13.14 GENEDATA
13.15 GENEGO
13.16 GENOLOGICS LIFE SCIENCES SOFTWARE INC
13.17 GENOMEQUEST
13.18 HELICOS BIOSCIENCES CORP
13.19 ILLUMINA INC
13.20 LIFE TECHNOLOGIES
13.21 MOLEGRO APS
13.22 NONLINEAR DYNAMICS
13.23 OCIMUM BIOSOLUTIONS
13.24 PHASE FORWARD INC
13.25 PREMIER BIOSOFT INTERNATIONAL
13.26 ROSETTA BIOSOFTWARE
13.27 SOFTGENETICS LLC
13.28 TEXTCO BIOSOFTWARE INC
13.29 TIBCO SPOTFIRE
13.30 TRIPOS INTERNATIONAL
APPENDIX
U.S. PATENTS
EUROPE PATENTS
JAPAN PATENTS
LIST OF TABLES
TABLE 1 GLOBAL BIOINFORMATICS MARKET, BY SEGMENTS 2007 – 2014 ($MILLION)
TABLE 2 GLOBAL BIOINFORMATICS PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 3 GLOBAL BIOINFORMATICS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 4 GLOBAL SEQUENCE ALIGNMENT PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 5 GLOBAL SEQUENCE ALIGNMENT PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 6 GLOBAL SEQUENCE ANALYSIS (ALIGNMENT) PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 7 GLOBAL SEQUENCE ANALYSIS (ALIGNMENT) PLATFORMS MARKET,BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 8 GLOBAL CONSENSUS SEQUENCE & TRANSLATION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 9 GLOBAL MULTIPLE SEQUENCE ALIGNMENT PLATFORMS MARKET,BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 10 GLOBAL PHYLOGENETIC TREE BUILDING PLATFORMS MARKET,BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 11 GLOBAL LAB END SEQUENCE ANALYSIS PLATFORMS MARKET,BY PRODUCTS 2007–2014 ($MILLION)
TABLE 12 GLOBAL LAB END SEQUENCE ANALYSIS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 13 GLOBAL CONTIG ASSEMBLY PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 14 GLOBAL PRIMER DESIGN & CLONING PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 15 GLOBAL SEQUENCE MANIPULATION PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 16 GLOBAL SEQUENCE MANIPULATION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 17 GLOBAL RANDOM SEQUENCES & FORMAT CONVERSION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 18 GLOBAL SEQUENCE ANALYSIS (SEQUENCE MANIPULATION) PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 19 GLOBAL SEQUENCE FIGURES PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 20 GLOBAL SEQUENCE ANALYSIS PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 21 GLOBAL SEQUENCE ANALYSIS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 22 GLOBAL DNA SEQUENCE ANALYSIS PLATFORMS MARKET,BY PRODUCTS 2007–2014 ($MILLION)
TABLE 23 GLOBAL DNA SEQUENCE ANALYSIS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 24 GLOBAL RESTRICTION, DETECT REPEATS, & UNUSUAL PATTERNS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 25 GLOBAL ALIGN SEQUENCES PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 26 GLOBAL SEARCH TOOLS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 27 GLOBAL PROTEIN FUNCTION ASSIGNMENT PLATFORMS MARKET,BY PRODUCTS 2007–2014 ($MILLION)
TABLE 28 GLOBAL PROTEIN FUNCTION ASSIGNMENT PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 29 GLOBAL SEARCH PATTERN, MOTIF, PROFILES DOMAINS, FAMILIES PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 30 GLOBAL PATHWAYS ANALYSIS & COMPUTATION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 31 GLOBAL PROTEIN-PROTEIN INTERACTION & PROTEIN ANNOTATION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 32 GLOBAL NEW SEQUENCE ALERT PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 33 GLOBAL RNA ANALYSIS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 34 GLOBAL ANALYZE & MODEL 3D STRUCTURE PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 35 GLOBAL ANALYZE & MODEL 3D STRUCTURE PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 36 GLOBAL 3D ANALYSIS & VIEWERS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 37 GLOBAL HOMOLOGY MODELING PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 38 GLOBAL PHYLOGENETIC ANALYSIS PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 39 GLOBAL PHYLOGENETIC ANALYSIS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 40 GLOBAL MULTIPLE SEQUENCE ALIGNMENT PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 41 GLOBAL ORGANISM CLASSIFICATION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 42 GLOBAL MICROARRAY DATA ANALYSIS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 43 GLOBAL STRUCTURAL ANALYSIS PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 44 GLOBAL STRUCTURAL ANALYSIS PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 45 GLOBAL PHYSIOCHEMICAL PROPERTIES & ALIGNMENT PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 46 GLOBAL PRIMARY SEQUENCE ANALYSIS PLATFORMS MARKET,BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 47 GLOBAL SECONDARY STRUCTURE SEQUENCE PREDICTION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 48 GLOBAL SEQUENCE VISUALIZATION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 49 GLOBAL OTHER PLATFORMS MARKET, BY PRODUCTS 2007–2014 ($MILLION)
TABLE 50 GLOBAL OTHER PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 51 GLOBAL VISUALIZATION PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 52 GLOBAL PHYSICAL MAPPING SOFTWARE PLATFORMS MARKET, BY GEOGRAPHY 2007–2014 ($MILLION)
TABLE 53 GLOBAL CONTENT/KNOWLEDGE MANAGEMENT TOOLS MARKET, 2007 – 2014 ($MILLION)
TABLE 54 GLOBAL CONTENT/KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 55 GLOBAL GENERALIZED KNOWLEDGE MANAGEMENT MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 56 GLOBAL GENERALIZED KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 57 GLOBAL PRIMARY SEQUENCE KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 58 GLOBAL PROTEIN SEQUENCE KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 59 GLOBAL CARBOHYDRATE KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 60 GLOBAL 3D STRUCTURE KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 61 GLOBAL SPECIALIZED KNOWLEDGE MANAGEMENT MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 62 GLOBAL SPECIALIZED KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 63 GLOBAL SPECIALIZED SEQUENCE KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 64 GLOBAL GENOME KNOWLEDGE MANAGEMENT MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 65 GLOBAL GENOME KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 66 GLOBAL COLLECTIONS MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 67 GLOBAL MODEL ORGANISM KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 68 GLOBAL SPECIALIZED PROTEIN KNOWLEDGE MANAGEMENT MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 69 GLOBAL SPECIALIZED PROTEIN KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 70 GLOBAL PROTEOME KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 71 GLOBAL SPECIFIC PROTEIN FAMILY KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 72 GLOBAL PROTEIN CLASSIFICATION KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 73 GLOBAL SPECIALIZED STRUCTURE KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 74 GLOBAL PATHWAY KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 75 GLOBAL MICROARRAY KNOWLEDGE MANAGEMENT MARKET,BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 76 GLOBAL 2D-PAGE KNOWLEDGE MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 77 GLOBAL BIOINFORMATICS SERVICES MARKET, BY PRODUCTS 2007-2014 ($MILLION)
TABLE 78 GLOBAL SERVICES MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 79 GLOBAL DATA ANALYSIS MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 80 GLOBAL DATA ANALYSIS MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 81 GLOBAL GENOMICS & PROTEOMICS DATA ANALYSIS MARKET,BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 82 GLOBAL MICROARRAY DATA ANALYSIS SERVICE MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 83 GLOBAL COMPUTATIONAL SERVICE MARKET, BY GEOGRAPHY 2007-2014 ($MILLION)
TABLE 84 GLOBAL SEQUENCING SERVICES MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 85 GLOBAL SEQUENCING SERVICES MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 86 GLOBAL SHOTGUN SEQUENCING MARKET, BY GEOGRAPHY 2007-2014 ($MILLION)
TABLE 87 GLOBAL PRIMER WALKING MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 88 GLOBAL EXPRESSION PROFILE CLUSTERING & SEQUENCE PATTERN MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 89 GLOBAL RE-SEQUENCING MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 90 GLOBAL HIGH THROUGHPUT SEQUENCING SERVICE MARKET, BY GEOGRAPHY 2007-2014 ($MILLION)
TABLE 91 GLOBAL MULTIPLE SEQUENCE ALIGNMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 92 GLOBAL DATABASE & MANAGEMENT MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 93 GLOBAL DATABASE & MANAGEMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 94 GLOBAL CONCEPTION & REALIZATION MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 95 GLOBAL USER INTERFACE DEVELOPMENT MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 96 GLOBAL MIGRATION MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 97 GLOBAL MAINTENANCE & BACKUP SYSTEM MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 98 GLOBAL OTHER SERVICES MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 99 GLOBAL OTHER SERVICES MARKET, BY GEOGRAPHY 2007 – 2014 ($MILLION)
TABLE 100 GLOBAL APPLICATIONS MARKET 2007 – 2014 ($MILLION)
TABLE 101 GLOBAL MOLECULAR MEDICINE MARKET, BY SEGMENTS 2007 – 2014 ($MILLION)
TABLE 102 GLOBAL GENE THERAPY MARKET, BY THERAPIES 2007 – 2014 ($MILLION)
TABLE 103 GLOBAL DRUG DEVELOPMENT MARKET, BY SEGMENTS 2007 – 2014 ($MILLION)
TABLE 104 GLOBAL OTHER APPLICATIONS MARKET, BY PRODUCTS 2007 – 2014 ($MILLION)
TABLE 105 MERGERS AND ACQUISITIONS (2008 TO 2009)
LIST OF FIGURES
FIGURE 1 COMPONENTS OF BIOINFORMATICS
FIGURE 2 BIOINFORMATICS MARKET SEGMENTATION
FIGURE 3 EFFECT OF MARKET TRANSITION ON BIOINFORMATICS
FIGURE 4 APPLICATION OF BIOINFORMATICS IN DRUG DEVELOPMENT
FIGURE 5 FEATURES OF BIOINFORMATICS PLATFORMS (2009 VS 2014)
FIGURE 6 PATENT ANALYSIS BY GEOGRAPHY (2006 VS 2008)
FIGURE 7 KEY FACTORS INFLUENCING BIOINFORMATICS MARKET
FIGURE 8 BIOINFORMATICS APPLICATION IN DATA MANAGEMENT
FIGURE 9 ROLE OF BIOINFORMATICS IN BIOMARKER DISCOVERY
FIGURE 10 ROLE OF IT IN BIOINFORMATICS
FIGURE 11 GLOBAL BIOINFORMATICS MARKET 2007 TO 2014 ($MILLION)
FIGURE 12 BIOINFORMATICS MARKET (NORTH AMERICA VS GLOBAL) 2007 TO 2014 ($MILLION)
FIGURE 13 BIOINFORMATICS MARKET (EUROPE VS GLOBAL) 2007 TO 2014 ($MILLION)
FIGURE 14 BIOINFORMATICS MARKET (ASIA VS GLOBAL) 2007 TO 2014 ($MILLION)
FIGURE 15 BIOINFORMATICS MARKET (ROW VS GLOBAL) 2007 TO 2014 ($MILLION)
FIGURE 16 KEY GROWTH STRATEGIES IN THE BIOINFORMATICS MARKET (JANUARY 2007 - MAY 2010)
FIGURE 17 AFFYMETRIX REVENUES, BY GEOGRAPHY (2009)
FIGURE 18 SHARE OF AGILENT’S BUSINESS SEGMENTS (2009)
FIGURE 19 AGILENT’S REVENUES 2005–2009 ($BILLION)
FIGURE 20 AGILENT’S TOTAL R&D EXPENDITURE 2007–2009 ($MILLION)
FIGURE 21 CELERA’S REVENUES, BY SEGMENTS ($MILLION) (2008 & 2009)
